Autoradiographic Distributions of Neurotransmitter Receptors in the Brain of Patients with Parkinson’s Disease and MPTP-induced Monkey Parkinsonism
Parkinson’s disease is a slowly progressive degenerative disorder which is pathologically characterized by neuronal loss of the substantia nigra. Biochemically, deficiency of dopamine in the striatum resulting from degeneration and loss of dopaminergic neurons in the substantia nigra has been confirmed. In addition, from experiments using autopsied human materials [1–6], abnormalities have been reported in the dopaminergic as well as in the following systems: acetylcholine, GABA, serotonin, noradrenaline, and peptide-containing neurons. Recently, it was discovered that 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), a by-product in the synthesis of MPPP (1-methyl-4-phenyl-4-propionoxy-piperidine), is selectively toxic to the zona compacta of the substantia nigra . In this paper, we report on observed distributions of neurotransmitter receptors in brains of patients with Parkinson’s disease and those of primate models with MPTP-induced parkinsonism.
KeywordsSubstantia Nigra Globus Pallidus Ergot Alkaloid Neurotransmitter Receptor Zona Compacta
Unable to display preview. Download preview PDF.
- 7.Burns RS, Chiueh CC, Markey SP, Ebert MH, Jacobowitz DM, Kopin IJ (1983) A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars com- pacta of the substantia nigra by N-methyl-4-phenyl-l,2,3,6-tetrahydropyridine. Proc Natl Acad Sci USA 80: 4546–4550PubMedCrossRefGoogle Scholar
- 9.Fuxe K, Agnati LF, Kohler C, Andersson K, Eneroth P, Calza L, Ogren SO (1983) Heterogeneity of brain dopamine systems: possible discrimination of different types of dopamine systems and receptors by ergot drugs. In: Calne DB (ed) Lisuride and other dopamine agonists. Raven, New York, pp 11–31Google Scholar
- 10.Spano PF, Govoni S, Uzumaki H, Bosio A, Memo M, Lucchi L, Carruba M, Trabucchi M (1983) Stimulation of D2 dopamine receptors by dopaminergic ergot alkaloids: studies on the mechanism of action. In: Agonoli A (ed) Aging brain and ergot alkaloids. Raven, New York, pp 165–177Google Scholar
- 11.Rosenfeld MR, Makman MH (1981) The interaction of lisuride, an ergot derivative, with serotonergic and dopaminergic receptors in rabbit brain. J Pharmacol and Exp Ther 216: 526–531Google Scholar
- 12.Cote TE, Eskay RL, Frey EA, Crewe CW, Munemura M, Tsuruta K, Brouwn EM, Kebabian JW (1983) Actions of lisuride on adrenoceptors and dopamine receptors. In: Calne DB (ed) Lisuride and other dopamine agonists. Raven, New York, pp 45–53Google Scholar